Norman J. Lacayo
Affiliations: | Pediatrics - Hematology & Oncology | Stanford University School of Medicine, Palo Alto, CA, United States |
Google:
"Norman Lacayo"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Chen KG, Duran GE, Mogul MJ, et al. (2020) Genomic stability at the coding regions of the multidrug transporter gene : insights into the development of alternative drug resistance mechanisms in human leukemia cells. Cancer Drug Resistance (Alhambra, Calif.). 3: 959-979 |
Karol SE, Cooper TM, Mead PE, et al. (2020) Safety, pharmacokinetics, and pharmacodynamics of panobinostat in children, adolescents, and young adults with relapsed acute myeloid leukemia. Cancer |
Chae HD, Dutta R, Tiu B, et al. (2020) RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit. Oncotarget. 11: 2387-2403 |
Wojcicki AV, Kasowski MM, Sakamoto KM, et al. (2020) Metabolomics in acute myeloid leukemia. Molecular Genetics and Metabolism |
Karol SE, Alexander TB, Budhraja A, et al. (2020) Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study. The Lancet. Oncology |
Wojcicki AV, Kadapakkam M, Frymoyer A, et al. (2020) Repurposing Drugs for Acute Myeloid Leukemia: A Worthy Cause or a Futile Pursuit? Cancers. 12 |
Brown P, Inaba H, Annesley C, et al. (2020) Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 18: 81-112 |
Huang M, Zeki J, Sumarsono N, et al. (2020) EPIGENETIC TARGETING OF TERT-ASSOCIATED GENE EXPRESSION SIGNATURE IN HUMAN NEUROBLASTOMA WITH TERT OVEREXPRESSION. Cancer Research |
Sanders LM, Lyle AG, Beale HC, et al. (2020) Abstract A44: Comparative gene expression analysis for identification and prioritization of therapeutic targets in a cohort of childhood cancers Cancer Research. 80 |
Rubnitz JE, Lacayo NJ, Inaba H, et al. (2019) Clofarabine Can Replace Anthracyclines and Etoposide in Remission Induction Therapy for Childhood Acute Myeloid Leukemia: The AML08 Multicenter, Randomized Phase III Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900327 |